Brimonidine Tartrate Ophthalmic Solution, 0.15% Solution/ Drops
Product Images NDC 46708-661

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate Ophthalmic Solution, 0.15% (NDC 46708-661). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimonidine-bottle-10ml (Brimonidine Bottle 10ml)

Brimonidine-bottle-10ml (Brimonidine Bottle 10ml)
Label for Brimonidine Tartrate ophthalmic solution 0.15%, sterile eye drops in a 10 mL container. The label includes dosage strength, sterilization status, manufacturer Alembic Pharmaceuticals Limited, NDC 46708-661-10, and storage instructions, along with an image of an eye graphic and a barcode.*
FDA Label Image

Brimonidine-bottle-15ml (Brimonidine Bottle 15ml)

Brimonidine-bottle-15ml (Brimonidine Bottle 15ml)
Label for Brimonidine Tartrate Ophthalmic Solution 0.15%, a sterile eye drop solution in a 15 mL container. The label includes the preservative stabilized oxychloro complex, dosage instructions, storage temperature, manufacturer Alembic Pharmaceuticals Limited, and a barcode with NDC 46708-661-15. The label also features the Alembic logo and an eye illustration.*
FDA Label Image

Brimonidine-bottle-5ml (Brimonidine Bottle 5ml)

Brimonidine-bottle-5ml (Brimonidine Bottle 5ml)
Label of Brimonidine Tartrate ophthalmic solution 0.15%, sterile 5 mL drops by Alembic Pharmaceuticals Limited. The label includes active ingredient concentration, preservative information, usual dosage directions, storage instructions, and manufacturing details, along with barcodes and space for lot and expiration dates.*
FDA Label Image

Brimonidine-carton-10ml (Brimonidine Carton 10ml)

Brimonidine-carton-10ml (Brimonidine Carton 10ml)
Brimonidine Tartrate Ophthalmic Solution 0.15% sterile solution drops in a 10 mL package labeled by Alembic Pharmaceuticals Limited. The label includes inactive ingredients and storage instructions, with dosage information specifying one drop three times daily to affected eyes. The product is marked Rx only and made in India.*
FDA Label Image

Brimonidine-carton-15ml (Brimonidine Carton 15ml)

Brimonidine-carton-15ml (Brimonidine Carton 15ml)
Packaging label for Brimonidine Tartrate ophthalmic solution 0.15%, a sterile eye drop solution. The label includes the active ingredient concentration (0.15%), NDC 46708-661-15, 15 mL volume, and manufacturer Alembic Pharmaceuticals Limited. The label also lists inactive ingredients, storage instructions, and administration directions, with branding and an eye illustration.*
FDA Label Image

Brimonidine-carton-5ml (Brimonidine Carton 5ml)

Brimonidine-carton-5ml (Brimonidine Carton 5ml)
Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.15%, sterile solution for ophthalmic use, labeled as Rx only. The label indicates a 5 mL content and shows the manufacturer as Alembic Pharmaceuticals Limited, with manufacturing details including location and date. The label includes active and inactive ingredients, usual dosage instructions, storage conditions, and a barcode with batch coding information.*
FDA Label Image

Brimonidine-structure (Brimonidine Structure)

Brimonidine-structure (Brimonidine Structure)
Chemical structure diagram depicting the active ingredient Brimonidine Tartrate. The structure includes a brominated quinoxaline moiety and a tartrate component illustrating the molecular arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.